Tango Therapeutics, Inc. - Common Stock (TNGX)
1.7300
-0.0500 (-2.81%)
Tango Therapeutics Inc is a biotechnology company focused on developing innovative therapies for the treatment of cancer
The company specializes in understanding the genetic and biological drivers of cancer, utilizing its expertise in synthetic lethality to create targeted treatments that aim to exploit specific vulnerabilities in cancer cells. Tango Therapeutics employs cutting-edge research and drug discovery techniques to identify and develop novel compounds that can improve patient outcomes, emphasizing precision medicine and personalized treatment approaches in oncology. Through their work, they aim to contribute significantly to the advancement of cancer care and the improvement of therapeutic options available to patients.
Frequently Asked Questions
Is Tango Therapeutics, Inc. - Common Stock publicly traded?
Yes, Tango Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Tango Therapeutics, Inc. - Common Stock trade on?
Tango Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tango Therapeutics, Inc. - Common Stock?
The ticker symbol for Tango Therapeutics, Inc. - Common Stock is TNGX on the Nasdaq Stock Market
What is the current price of Tango Therapeutics, Inc. - Common Stock?
The current price of Tango Therapeutics, Inc. - Common Stock is 1.730
When was Tango Therapeutics, Inc. - Common Stock last traded?
The last trade of Tango Therapeutics, Inc. - Common Stock was at 3:27 pm EDT on March 21st, 2025